Tooru (formerly Riverfort Global Opportunities) , a health and wellness-focused company, announced its interim results for the 6 months ended June 30, 2025 (H1 2025). During the period, Riverfort completed the acquisition of S-Ventures' wellness portfolio, marking its transformation from an investment vehicle to an operational company in the health and wellness sector under the Tooru name.
Tooru was admitted to the AIM market on May 29, 2025 under the ticker TOO. The enlarged group inherited a diverse portfolio of businesses from S-Ventures, including plantain snack brand We Love Purely, protein bar manufacturer Pulsin, gluten-free food specialist Juvela, and e-commerce consultancy Market Rocket.
Following the reverse takeover, three SVEN board members assumed senior board positions in the company as S-Ventures is now its largest shareholder with 27.8% interest. Scott Livingston, founder of S-Ventures, emerged as a major shareholder in Tooru with 35% stake on admission.
Operationally, a key highlight in H1 was Juvela's introduction of its OAF range of gluten-free breads to Tesco shelves, featuring a 4-variant lineup. The product uses a specially formulated wheat starch with gluten removed - a process traditionally reserved for prescription coeliac bread that delivers taste and texture much closer to regular bread than competing products that use rice flower.
Tooru is in advanced negotiations with other major UK supermarkets to list the new product line. Financially, Juvela made good progress during the period, nearly doubling total EBITDA to £750k, while significant new capital was invested to build a new "free-from" production line to support future expansion.
Similarly, Pulsin and We Love Purely were restructured, resulting in a marked turnaround in financial performance, with Pulsin significantly reducing losses and achieving positive EBITDA. Tooru is relocating both operations from Gloucester to Wales to co-locate with Juvela, expected to generate substantial cost savings.
Overall, Tooru's first reporting period since the acquisition of S-Ventures' wellness portfolio is highly encouraging. The group achieved a positive EBITDA of £0.78m on £6.2m of sales, a marked improvement compared to the same period in FY24, underscoring the value and growth potential of the acquired businesses.
Looking ahead, there is significant upside from ongoing investment and development of S-Ventures' portfolio, leveraging cross-selling opportunities, efficiency improvements, and economies of scale. Additional acquisition opportunities are also being explored, promising further growth.
Follow News & Updates from Tooru: